Clopidogrel for staph bloodstream infections
Treatments studied
Part of Infections clinical trials.
This trial tests whether adding clopidogrel, a blood thinner, to standard care can help treat staph bloodstream infections. It may reduce the risk of complications, but it is only for patients who can take oral medications and are not at high risk of bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed staph infection in your blood.
- You must be in the hospital when you join the study.
- The study team must evaluate you within 72 hours of your first positive blood test.
- You must be able to take oral medications and have normal liver function.
- You cannot be pregnant or breastfeeding.
- You must not have recent bleeding, planned surgery, or be taking certain blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two blood-thinning medicines, clopidogrel and aspirin, to see which better prevents heart attacks and strokes in people who have had a staph infection in their blood. If you already take aspirin for heart or blood vessel problems, this study may help find the safest way to protect your heart.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
This study compares two types of blood thinners (dabigatran vs. a common Xa inhibitor like apixaban) in people with a staph infection in their blood. The goal is to see which is safer and works better.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
Hear when a new Bacteremia Due to Staphylococcus Aureus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.